ZM447439 is the first Aurora family kinase inhibitor with IC50 of 50 nM for Aurora B kinase.
ZM447439 is the first Aurora family kinase inhibitor with IC50 of 50 nM for Aurora B kinase.
ZN-c3 is a potentially first-in-class and best-in-class orally active, potent and selective Wee1 inhibitor (IC50=3.9 nM). zN-c3 can be used in cancer research.
ZN-c3 is a potentially first-in-class and best-in-class orally active, potent and selective Wee1 inhibitor (IC50=3.9 nM). zN-c3 can be used in cancer research.
ZN-c3 is a potentially first-in-class and best-in-class orally active, potent and selective Wee1 inhibitor (IC50=3.9 nM). zN-c3 can be used in cancer research.
ZN-c3 is a potentially first-in-class and best-in-class orally active, potent and selective Wee1 inhibitor (IC50=3.9 nM). zN-c3 can be used in cancer research.
Zofenopril Calcium is an antioxidant that acts as an angiotensin-converting enzyme (ACE)inhibitor.
Zofenopril Calcium is an antioxidant that acts as an angiotensin-converting enzyme (ACE)inhibitor.
Zofenopril Calcium is an antioxidant that acts as an angiotensin-converting enzyme (ACE)inhibitor.
Zofenopril Calcium is an antioxidant that acts as an angiotensin-converting enzyme (ACE)inhibitor.
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors.
Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors.